Jurnal Ekonomi Kesehatan Indonesia最新文献

{"title":"Increasing Cigarette Excise Tax Prevents Smoking Initiation in Children and Finances National Health Insurance in Indonesia","authors":"Ayu Purnamasari, P. Pujiyanto, H. Thabrany, R. Nurhasana, A. Satrya, T. Dartanto","doi":"10.7454/EKI.V3I2.3033","DOIUrl":"https://doi.org/10.7454/EKI.V3I2.3033","url":null,"abstract":"AbstractIndonesia has ranked third among countries with the highest number of smokers in Asia because the price of cigarettes in those countries is still affordable. The strategy to make the price of cigarettes is not affordable is increasing cigarette excise tax. This instrument is considered the most effective way to control cigarette consumption. The purpose of this study was to find out how the public perceive the increase of the cigarette excise tax to cover the National Health Insurance (NHI) deficit and to identify the factors which affect such perception. This study used mobile phone survey and the sample were 1000 respondents. The list of potential respondent’s mobile phone numbers was selected using the systematic random sampling method with an interval of 100,000 to 200,000. The result showed that 87.9% respondents agree to increase cigarette price so that the children do not start to smoke. The majority of respondents (86.2%) also agree to increase the price of cigarettes to finance the JKN deficit. Perceptions of respondents who agreed to increase the price of cigarettes to prevent smoking initiation in children also tended to accede the increase in cigarette prices for financing the JKN deficit.  Abstrak Indonesia menempati peringkat ketika jumlah perokok tertinggi di Asia karena harga rokok masih terjangkau. Strategi agar harga rokok tidak terjangkau adalah menaikkan cukai rokok. Instrumen tersebut dinilai paling efektif untuk mengendalikan konsumsi rokok. Tujuan penelitian adalah untuk mengetahui bagaimana persepsi masyarakat terhadap kenaikan cukai rokok untuk pembiayaan Jaminan Kesehatan Nasional (JKN) dan mengidentifikasi faktor yang memengaruhi persepsi tersebut. Metode penelitian menggunakan survei melalui telepon dengan sampel 1000 responden. Daftar nomor telepon seluler calon responden dipilih dengan cara systematic random sampling interval 100.000 sampai 200.000. Hasil penelitian menunjukkan bahwa 87,9% setuju harga rokok dinaikkan agar anak-anak tidak mulai merokok. Mayoritas responden (86,2%) juga setuju mengenai kenaikan harga rokok untuk pembiayaan defisit JKN. Persepsi responden yang setuju terhadap kenaikan harga rokok agar mencegah inisisasi merokok pada anak-anak juga cenderung setuju terhadap kenaikan harga rokok untuk pembiayaan defisit JKN. ","PeriodicalId":427313,"journal":{"name":"Jurnal Ekonomi Kesehatan Indonesia","volume":"169 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-06-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132641723","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Evaluasi Ekonomi Penggunaan Antibiotika Profilaksis Cefotaxime dan Ceftriaxone pada Pasien Operasi Seksio Sesarea di Rumah Sakit X","authors":"Echa Aisyah, Mardiati Nadjib","doi":"10.7454/EKI.V3I2.3160","DOIUrl":"https://doi.org/10.7454/EKI.V3I2.3160","url":null,"abstract":"AbstrakPemberian antibiotik profilaksis pada operasi seksio sesarea sangat dianjurkan. Menurut pedoman umum penggunaan antibiotik obat dipilih atas dasar keamanan dan efektivitas biaya. Evaluasi ekonomi parsial berupa analisis biaya dan luaran ini menggunakan metode alongside observational study, data dikumpulkan selama bulan April–Mei 2017 secara prospektif mencakup 60 pasien dengan operasi seksio sesarea yang mendapatkan antibiotik profilaksis, membandingkan efektivitas biaya antara Cefotaxime dan Ceftriaxone. Hasil uji statistik menunjukkan bahwa tidak ada perbedaan karakteristik pada 60 pasien tersebut. Analisis menggunakan perspektif rumah sakit, dilaksanakan di rumah sakit milik Pemerintah di Jawa Barat. Hasil Systematic Review menunjukkan bahwa tidak ada perbedaan efikasi pada penggunaan kedua obat tersebut. Hasil penelitian ini menkonfirmasi bahwa tidak ada perbedaan outcome klinis (berupa infeksi luka operasi) antara pasien yang mendapatkan antibiotik profilaksis Ceftriaxone dengan antibiotik Cefotaxime. Komponen biaya terbesar adalah biaya operasional (84,79%), diikuti biaya alokasi dari unit penunjang (13,68%), biaya investasi (1,2%) dan biaya pemeliharaan (0,32%). Analisis biaya satuan memberikan hasil biaya inkremental sebesar Rp. 342.535 pada satu episode rawat inap. Rumah sakit memiliki potensi untuk menghemat sebesar Rp. 317.529.945 setahun dengan memilih antibiotik profilaksis Cefotaxime pada pasien operasi seksio sesarea. AbstractA prophylactic antibiotic for patients with cesarean section surgery is highly recommended in the clinical guideline. The use of antibiotics is selected by using criteria safety and cost-effectiveness. This partial economic evaluation in the form of cost and outcome analysis was using alongside observational study method, prospective data were collected from April to May 2017 covering 60 patients with cesarean section surgery who received prophylaxis antibiotics, comparing cost-effectiveness between Cefotaxime and Ceftriaxone. The statistical test showed that there were no differences of characteristics in the 60 patients. The analysis based on the hospital perspective carried out in a public hospital in West Java. The Systematic Review showed that there was no difference in the efficacy of the drugs. This study confirmed that there was no difference in clinical outcome on surgical wound infections either in the patient who received Ceftriaxone prophylaxis or Cefotaxime. The greatest component of the cost was the operational cost (84.79%), followed by indirect cost (13.68%), investment cost (1.2%), and maintenance cost (0.32%). The analysis suggested the incremental cost was IDR342,535 in one episode of treatment. The hospital would save the cost of IDR317,529,945 a year by choosing Cefotaxime prophylactic antibiotics for patients with cesarean section surgery.","PeriodicalId":427313,"journal":{"name":"Jurnal Ekonomi Kesehatan Indonesia","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-06-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129736817","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Analisis Kesiapan Pembiayaan Hipertensi, Diabetes Melitus dan Gangguan Jiwa dalam Mendukung Program Indonesia Sehat dengan Pendekatan Keluarga (PIS PK) Tahun 2018-2020","authors":"T. Astuti, Prastuti Soewondo","doi":"10.7454/EKI.V3I1.2429","DOIUrl":"https://doi.org/10.7454/EKI.V3I1.2429","url":null,"abstract":"AbstrakProgram Indonesia Sehat dengan Pendekatan Keluarga (PIS PK) merupakan cara Puskesmas untuk meningkatkan jangkauansasaran dan akses pelayanan kesehatan dengan mendatangi keluarga. Skala prioritas nasional dalam mencapai IndonesiaSehat salah satunya adalah menanggulangi penyakit tidak menular termasuk hipertensi, Diabetes Melitus dan Gangguan Jiwayang prevalensinya semakin meningkat. Hipertensi, Diabetes Melitus dan Gangguan Jiwa merupakan salah satu indikatorkeluarga sehat dalam PIS PK untuk mencapai SPM. Penelitian ini menggunakan metode kualitatif dengan teknik wawancaramendalam dan telaah dokumen. Kesiapan pembiayaan Hipertensi, Diabetes Melitus dan Gangguan Jiwa dihitung denganmenggunakan metode costing SPM. Hasil penelitian menunjukkan bahwa belanja kesehatan untuk PIS PK digunakan untuksosialisasi, edukasi dan pendataan. Mengacu pada perhitungan costing SPM, Kota Depok mampu melaksanakan SPM untukPelayanan Dasar Hipertensi, Diabetes Melitus dan Gangguan Jiwa karena hanya menggunakan 1,38% APBD KesehatanBelanja Langsung (Non Gaji). Akan tetapi, Kota Depok belum siap dalam melaksanakan PIS PK dalam hal komitmen, SDM,dan anggaran. Kota Depok sudah memahami PIS PK namun pelaksanaannya tergantung pada ketersediaan pembiayaan yangberasal dari pencairan anggaran DAK Non Fisik. Hal ini disebabkan karena terdapat jeda waktu antara proses pengusulandan realisasi pencairan anggaran sementara SDM terbatas. Diperlukan proses perencanaan yang lebih optimal sertapengalokasian SDM sesuai kebutuhan.AbstractHealthy Indonesia Program with Family Approach (PIS PK) is a way to expand Puskesmas reach and access to health servicesthrough family home visit Overcoming non-communicable diseases (NCD) is a national priority in achieving Healthy Indonesiabecause the prevalence of NCD continues to increase. Managing NCD specifically hypertension, Diabetes Mellitus andmental disorders are among the indicators of healthy families in achieving PIS PK.This research uses the qualitative methodthrough in-depth interviews and related document. Analysis of readiness of financing for hypertension, Diabetes Mellitusand mental is calculated using costing methode of SPM. The results indicated health spending for PIS PK activities wereutilized for socialization, education and data collection. Referring to SPM costing calculation, the City of Depok was able toimplement SPM for hypertension, Diabetes Mellitus and Mental Disorder with using only 1.38% of the total APBD (non-salary).Depok City is not ready in implementing PIS PK, specifically in terms of commitment, human resources, and budget.Though already familiar with PIS PK, Depok City states due to its limited resources, PIS PK implementation depends on theavailability of funding from Non-Physical DAK disbursement that tends to have a lengthy lag time between the proposal processand the realization of the disbursement. The financing of PIS PK requires a more optimal planning process and allocationof human resources as neede","PeriodicalId":427313,"journal":{"name":"Jurnal Ekonomi Kesehatan Indonesia","volume":"15 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131636193","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Cost Benefit Analysis (CBA) Program Pemberian Makanan Tambahan (PMT) Susu Pada Karyawan di PT. Trisula Textile Industries Tbk Cimahi Tahun 2018","authors":"Ayu Laili Rahmiyati, A. Abdillah, S. Susilowati, Dinna Anggaraini","doi":"10.7454/eki.v3i1.2740","DOIUrl":"https://doi.org/10.7454/eki.v3i1.2740","url":null,"abstract":"AbstrakCost Benefit Analysis (CBA) digunakan untuk proses identifikasi, pengukuran dan perbandingan sosial manfaat dan biayaproyek atau program investasi dalam mengevaluasi penggunaan sumber daya ekonomi yang langka agar dapat digunakansecara efisien. Penelitian ini bertujuan untuk mengetahui perhitungan manfaat dan biaya dari program Pemberian MakananTambahan (PMT) susu di PT. Trisula Textile Industries Tbk Tahun 2018 dan untuk menetukan kelayakan akan keberlangsunganprogram atau kebijakan dari PMT susu. Penelitian ini menggunakan pendekatan kuantitatif.Pengumpulan data dilakukanmelalui wawancara, observasi, dan telaah dokumen. Analisis perhitungan menggunakan Payback Period (PP), Net PresentValue (NPV), Internal Rate Of Return (IRR), dan Benefit Cost Rate (BCR). Hasil perhitungan nilai NPV pada program PMTsusu adalah Rp. 23.534.448,76,-. Kesimpulannya adalah program PMT susu dapat diterima karena NPV > 0. Hasil perhitunganrasio benefit-cost adalah sebesar 2,50 (hasil rasio ≥ 1), artinya program PMT susu tersebut layak untuk tetap berlangsung. PT.Trisula Textile Industries Tbk diharapkan dapat melanjutkan program PMT susu pada karyawan. Data dasar penelitian dapatdijadikan bahan kajian bagi perusahaan untuk menyusun program kesehatan atau peningkatan kesehatan bagi karyawanmelalui PMT atau program lain yang lebih prioritas.AbstractCost Benefit Analysis (CBA) for the process of identification , measurement,comparison social benefits and cost project or investmentprogram to evaluate utilization of scarce economic resources so that it can be used efficiently .This research purposes are calculateingbenefits and cost in rupiah from the milk supplementary feeding program (PMT) at PT. Trisula Textile Industries Tbk Year 2018 anddeciding feasibility of program or policy sustainability from PMT milk. The research is using quantitative approach. Data collectionis done through interviews, observations, and study documents. Calculation is using Payback Period (PP), Net Present Value (NPV),Internal Rate Of Return (IRR), and Benefit Cost Rate (BCR). The result showscalculation of NPV value on milk PMT program obtainedresults end Rp. 23,534,448,76, -. To conclude, the milk PMT program is acceptable because NPV> 0. Benefit-cost ratio , is 2.50 (≥ 1),meaning the milk PMT program is feasible. PT. Trisula Textile Industries Tbk is expected to continue the program of milk PMT. Basicresearch data could be used for preparing health program or health enhancement for employees through PMT or the other priorityprograms.","PeriodicalId":427313,"journal":{"name":"Jurnal Ekonomi Kesehatan Indonesia","volume":"132 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115557955","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Risk Adjustment of Capitation Payment System: What Can Indonesia Adopt from other Countries?","authors":"Asri Hikmatuz Zahroh, R. A. Putri, Latanza Shima, Erdayani Erdayani, Rira Martaliza, T. Anggoro, Wulansari Wulansari","doi":"10.7454/EKI.V3I1.2408","DOIUrl":"https://doi.org/10.7454/EKI.V3I1.2408","url":null,"abstract":"AbstractCapitation calculation in Indonesia is not adjusted by individual and aggregate risk. Without risk adjustment, capitation ratesare likely to overpay or underpay primary care. This study aimed to review risk-adjusted capitation payment in other countriesfor evaluation of capitation payment system in Indonesia. The conduct and reporting of this systematic review followedthe recommendations of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). This studyused comprehensive electronic search in five databases: Pubmed, Proquest, Scopus, PMC, and EBSCOHost. Search resultsfrom five databases in April 2018, yielded a total 19 titles that will continue to review the full article and at the end, 4 articlesincluded for systematic review. Based on risk adjustment of capitation payment system in UK, USA, Canada and Sweden,Indonesia may initiate the use of risk adjustment based on the distribution of age and sex. Then Indonesia can develop riskadjustment based on diagnosis and socioeconomic factors to create more fair and accurate capitation rates for primary care.AbstrakPerhitungan kapitasi di Indonesia belum disesuaikan berdasarkan risiko individu dan agregat. Tanpa penyesuaian risiko, rate kapitasicenderung untuk membayar lebih atau kurang fasilitas kesehatan tingkat pertama. Studi ini bertujuan untuk meninjau sistem pembayarankapitasi di negara lain sebagai dasar evaluasi untuk sistem pembayaran kapitasi di Indonesia Penyusunan systematic review inimenggunakan rekomendasi dari Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). Studi ini mengumpulkanartikel dari lima database yaitu: Pubmed, Proquest, Scopus, PMC, and EBSCOHost. Hasil pencarian dari lima database padabulan April 2018, didapatkan 19 judul artikel yang akan dilanjutkan untuk ditinjau secara menyuluruh, dan akhirnya didapatkan 4artikel yang akan diikutsertakan dalam systematic review. Berdasarkan penyesuaian risiko sistem pembayaran kapitasi di UK, USA,Canada dan Swedia, Indonesia dapat memulai sistem pembayaran kapitasi berdasarkan penyesuiaan distribusi umur dan jenis kelamin.Selanjutnya Indonesia dapat mengembangkan sistem pembayaran kapitasi berdasarkan diagnosis dan sosioekonomi untukmenciptakan rate kapitasi yang lebih adil dan akurat untuk fasilitas kesehatan tingkat pertama.","PeriodicalId":427313,"journal":{"name":"Jurnal Ekonomi Kesehatan Indonesia","volume":"2 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127404859","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"ECONOMIC EVALUATION OF CETUXIMAB FOR METASTATIC COLORECTAL CANCER (mCRC): A PROTOCOL FOR EVIDENCE SYNTHESIS","authors":"S. Putri, Ery Setiawan, S. R. F. Saldi, L. Chandra, A. Megraini, Vetty Yulianty P","doi":"10.7454/EKI.V3I1.2304","DOIUrl":"https://doi.org/10.7454/EKI.V3I1.2304","url":null,"abstract":" ABSTRACTColorectal cancer is fairly common compared to other cancers. The incidence and mortality rates are predicted to increase globally. In some cases, cancer can be potentially spread to another organ or metastatic. One of recent available targeted therapies for metastatic colorectal cancer (mCRC) patient is Cetuximab (Erbitux ®), combined with chemotherapy. Despite clinical effectiveness, there is the importance of the evidence related cost-effectiveness of therapy. This study aims to summary, synthesize, and systematically review the economic evaluation studies of Cetuximab for metastatic colorectal cancer (mCRC). Model based economic evaluation of Cetuximab for metastatic colorectal cancer will be searched and included in the review based on specific eligibility criteria. Several electronic databases that will be used: Medline, Embase, Cochrane, National Institute of Health Research (NIHR) Center for Reviews and Dissemination. Full economic evaluation evidence will be summarized and critically appraised using Drummond as well as (Consolidated Health Economic Evaluation Reporting Standards (CHEERS) checklist. In terms of analysis, we will qualitatively appraise and present the studies that meet our inclusion and exclusion criteria. We are expected to summarize the quality and capture the valuable insights related to health economic evaluation studies of Cetuximab for mCRC patient. ABSTRAKKanker kolorektal cukup umum terjadi dibandingkan kanker lainnya, angka kejadian dan angka kematian diprediksi meningkat secara global. Dalam beberapa kasus, kanker berpotensi menyebar ke organ lain atau disebut metastasis. Salah satu terapi yang ditargetkan baru-baru ini untuk pasien kanker kolorektal metastatik (mCRC) adalah Cetuximab (Erbitux®), yang dikombinasikan dengan kemoterapi. Meskipun terdapat bukti klinis, penting untuk mempertimbangkan bukti terkait efektivitas biaya dari terapi tersebut. Penelitian ini bertujuan untuk merangkum, mensintesis, dan meninjau secara sistematis studi evaluasi ekonomi Cetuximab untuk kanker kolorektal metastatik (mCRC). Evaluasi ekonomi berbasis model untuk menilai Cetuximab pada kanker kolorektal metastatik akan ditelusuri sesuai dengan kriteria yang ditetapkan. Beberapa database elektronik yang akan digunakan: Medline, Embase, Cochrane, Pusat Penelitian Kesehatan Nasional (NIHR) untuk Tinjauan dan Diseminasi. Bukti evaluasi ekonomi lengkap akan dirangkum dan dinilai secara kritis dengan menggunakan daftar pertanyaan oleh Drummond dan juga Consolidated Health Economic Evaluation Reporting Standards (CHEERS). Dalam hal analisis, kami akan menilai dan menyajikan secara kualitatif studi yang memenuhi kriteria inklusi dan eksklusi. Kami berekspektasi untuk meyimpulkan kualitas dan menangkap informasi yang berkaitan dengan studi evaluasi ekonomi pada Cetuximab untuk pasien mCRC.","PeriodicalId":427313,"journal":{"name":"Jurnal Ekonomi Kesehatan Indonesia","volume":"26 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122775213","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Efektivitas Biaya Strategi DOTS Program Tuberkulosis antara Puskesmas dan Rumah Sakit Swasta Kota Depok","authors":"Fikrotul Ulya, Hasbullah Thabrany","doi":"10.7454/EKI.V3I1.2321","DOIUrl":"https://doi.org/10.7454/EKI.V3I1.2321","url":null,"abstract":"AbstrakAngka penemuan Tuberkulosis (TB) tahun 2016 adalah sebesar 77% di dunia, sebesar 46,5% di Asia Tenggara dan sekitar32 - 33% di Indonesia. Di Kota Depok angka penemuan TB mencapai 58%. Sektor swasta menjangkau 18,7% kasus TB di KotaDepok meskipun baru 40% RS swasta yang terlibat. Penelitian ini bertujuan untuk mengetahui apakah penerapan strategiDOTS di Rumah Sakit swasta Kota Depok lebih menghemat biaya dibandingkan di Puskesmas. Penelitian dilakukan selama 6bulan dengan kohort retrospektif di Puskesmas DOTS, RS DOTS dan RS Non DOTS menggunakan 36 sampel per kelompok.Penghitungan dari perspektif societal dengan microcosting berdasarkan tarif, harga pasar, serta nilai anggaran. Outputnyaangka pengobatan lengkap (Success Rate). Hasil penelitian menunjukkan Success Rate di puskesmas paling tinggi yaitu86,1%, RS DOTS sebesar 77.78 % dan Non DOTS 63.89 %. Penambahan biaya provider terutama tenaga pelaksana khususdi puskesmas dan RS DOTS meningkatkan success rate. Biaya societal di puskesmas 42% dari biaya di RS swasta. ACER(Average Cost Effectiveness Ratio) menunjukkan RS yang melaksanakan strategi DOTS lebih cost effective. Untuk menaikkan1% angka kesuksesan pengobatan membutuhkan biaya Rp 10.084.572 dengan melakukan intervensi program DOTS ke RSSwasta. Uji t independen menyatakan bahwa terdapat perbedaan bermakna biaya societal pengobatan tuberkulosis antarapuskesmas, RS DOTS, dan RS Non DOTS. AbstractGlobal TB notification rate at 2016 was 77% and 46.5% in Southeast Asia. Indonesia last 5 years still remain at 32-33% where DepokCity reached 58%. In Depok City, private sector contributed 18.7% of the notified TB case in 2016 although only 40% of privatehospitals were involved. The aims of this study is to determine cost-effectiveness of DOTS strategy implementation at private hospitaland Public Health Centre (PHC). Comparative study carried out for six months with cohort retrospective between PHC, DOTS andNon DOTS hospitals using 36 samples per group. The calculation of the societal perspective with microcosting based on tariffs, marketprices and budget value. Output is Success Rate, where at PHC 86.1%, DOTS hospital 77.78% and Non DOTS hospital 63.89%.The addition cost providers especially person in charge at PHC and DOTS hospital increase success rate. The cost of TB treatmentin PHC 42% of private hospital. ACER (Average Cost Effectiveness Ratio) is obtained that the hospital which carry out the DOTSstrategy is cost effective. To increase 1% success rate of TB treatment costs Rp 10,084,572 with intervention DOTS programs into aprivate hospital. An Independen t test stated that cost-effectiveness societal perspectives on TB treatment has a significant differencebetween PHC, DOTS hospital and Non DOTS hospital .","PeriodicalId":427313,"journal":{"name":"Jurnal Ekonomi Kesehatan Indonesia","volume":"8 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132848013","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}